应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
03692 翰森制药
休市中 05-03 16:09:00
18.240
+0.060
+0.33%
最高
18.500
最低
17.980
成交量
336.48万
今开
18.200
昨收
18.180
日振幅
2.86%
总市值
1,083亿
流通市值
1,083亿
总股本
59.36亿
成交额
6,125万
换手率
0.06%
流通股本
59.36亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
翰森制药05月02日获主力加仓1180万元 环比增加730.99%
自选股智能写手 · 05-02 16:15
翰森制药05月02日获主力加仓1180万元 环比增加730.99%
翰森制药(03692)上涨5.17%,报18.3元/股
金融界 · 05-02 10:46
翰森制药(03692)上涨5.17%,报18.3元/股
翰森制药盘中异动 股价大涨5.40%
自选股智能写手 · 05-02 10:46
翰森制药盘中异动 股价大涨5.40%
南向资金4月30日净卖出翰森制药44.60万股 连续5日减持
自选股智能写手 · 05-02 09:30
南向资金4月30日净卖出翰森制药44.60万股 连续5日减持
翰森制药(03692):谭思慧已获委任为联席公司秘书
智通财经 · 04-29
翰森制药(03692):谭思慧已获委任为联席公司秘书
翰森制药(03692)将于7月17日派发末期股息每股0.1422港元
智通财经 · 04-29
翰森制药(03692)将于7月17日派发末期股息每股0.1422港元
翰森制药04月29日主力资金流入453万元 连续5日加仓
自选股智能写手 · 04-29
翰森制药04月29日主力资金流入453万元 连续5日加仓
《半日速报》恒指升226点; 恒生科技指数升30点 友邦升逾7% 平安升逾3% 中行、翰森制药、海尔智家、小米集团、大新金融创新高
阿斯达克财经 · 04-29
《半日速报》恒指升226点; 恒生科技指数升30点 友邦升逾7% 平安升逾3% 中行、翰森制药、海尔智家、小米集团、大新金融创新高
南向资金4月26日净卖出翰森制药35.00万股 连续3日减持
自选股智能写手 · 04-29
南向资金4月26日净卖出翰森制药35.00万股 连续3日减持
复宏汉霖曲妥珠单抗获FDA批准上市、翰森制药引进荃信生物一款自免单抗、一款国产PDE4抑制剂申报上市
医药经济报 · 04-26
复宏汉霖曲妥珠单抗获FDA批准上市、翰森制药引进荃信生物一款自免单抗、一款国产PDE4抑制剂申报上市
翰森制药:荃信生物获独家许可 7500万元首付款最高10.32亿元里程碑付款
和讯网 · 04-25
翰森制药:荃信生物获独家许可 7500万元首付款最高10.32亿元里程碑付款
翰森制药(03692)附属与荃信生物订立许可协议
智通财经 · 04-25
翰森制药(03692)附属与荃信生物订立许可协议
荃信生物-B(02509)与翰森(上海)健康科技就QX004N订立独家对外授权协议
智通财经 · 04-25
荃信生物-B(02509)与翰森(上海)健康科技就QX004N订立独家对外授权协议
翰森制药(03692.HK)与荃信生物-B(02509.HK)签订QX004N对外授权协议 首付款7,500万人币
阿斯达克财经 · 04-25
翰森制药(03692.HK)与荃信生物-B(02509.HK)签订QX004N对外授权协议 首付款7,500万人币
翰森制药04月25日主力资金流入349万元 连续3日加仓
自选股智能写手 · 04-25
翰森制药04月25日主力资金流入349万元 连续3日加仓
翰森制药(03692)出现大手买入36.2万股,成交价$16.28,涉资589.336万
阿斯达克财经 · 04-23
翰森制药(03692)出现大手买入36.2万股,成交价$16.28,涉资589.336万
翰森制药盘中异动 下午盘股价大涨5.06%
自选股智能写手 · 04-22
翰森制药盘中异动 下午盘股价大涨5.06%
翰森制药(03692)根据受限制股份单位的计划发行230万股公司股份
智通财经 · 04-19
翰森制药(03692)根据受限制股份单位的计划发行230万股公司股份
南向资金4月18日净卖出翰森制药100.80万股 连续7日减持
自选股智能写手 · 04-19
南向资金4月18日净卖出翰森制药100.80万股 连续7日减持
翰森制药盘中异动 快速跳水5.06%
自选股智能写手 · 04-16
翰森制药盘中异动 快速跳水5.06%
公司概况
公司名称:
翰森制药
所属市场:
SEHK
上市日期:
--
主营业务:
翰森制药集团有限公司是一家主要从事药品研发、生产及销售业务的中国投资控股公司。该公司的主要产品包括欧兰宁、阿美宁、普来乐、泽菲、昕维、昕美、泽坦、迈灵达、恒捷、恒森、孚来迪和瑞波特等。该公司产品主要用于中枢神经系统疾病、抗肿瘤、抗感染、糖尿病、消化道和心血管治疗。该公司主要在中国内地销售产品。
发行价格:
--
{"stockData":{"symbol":"03692","market":"HK","secType":"STK","nameCN":"翰森制药","latestPrice":18.24,"timestamp":1714723740031,"preClose":18.18,"halted":0,"volume":3364767,"delay":0,"floatShares":5935650070,"shares":5935650070,"eps":0.60214007,"marketStatus":"休市中","marketStatusCode":7,"change":0.06,"latestTime":"05-03 16:09:00","open":18.2,"high":18.5,"low":17.98,"amount":61254677,"amplitude":0.028603,"askPrice":18.24,"askSize":238000,"bidPrice":18.22,"bidSize":44000,"shortable":3,"etf":0,"ttmEps":0.5688368523547612,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1714959000000},"adr":0,"listingDate":1560441600000,"adjPreClose":18.18,"dividendRate":0.01151,"openAndCloseTimeList":[[1714699800000,1714708800000],[1714712400000,1714723200000]],"volumeRatio":0.5766381719566821,"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/03692/wiki","defaultTab":"wiki","newsList":[{"id":"2432289356","title":"翰森制药05月02日获主力加仓1180万元 环比增加730.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432289356","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432289356?lang=zh_cn&edition=full","pubTime":"2024-05-02 16:15","pubTimestamp":1714637727,"startTime":"0","endTime":"0","summary":"05月02日, 翰森制药股价涨4.48%,报收18.18元,成交金额1.10亿元,换手率0.10%,振幅7.13%,量比1.09。翰森制药今日主力资金净流入1180万元,连续7日净流入,上一交易日主力净流入142万元,今日环比增加730.99%。该股近5个交易日上涨7.26%,主力资金累计净流入2720万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流入4234万元,其中净流入天数为14日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405021615388b6c5f28&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405021615388b6c5f28&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432694654","title":"翰森制药(03692)上涨5.17%,报18.3元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2432694654","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2432694654?lang=zh_cn&edition=full","pubTime":"2024-05-02 10:46","pubTimestamp":1714617996,"startTime":"0","endTime":"0","summary":"5月2日,翰森制药(03692)盘中上涨5.17%,截至10:46,报18.3元/股,成交3332.58万元。翰森制药集团有限公司是中国规模最大、增长最快的研发驱动型制药公司之一,主要在中枢神经系统、抗肿瘤、抗感染和糖尿病等治疗领域确立了领先地位。同时,该公司也在消化道和心血管治疗领域进行了深入研究和开发。截至2023年年报,翰森制药营业总收入101.04亿元、净利润32.78亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/05/02104640509090.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2432694223","title":"翰森制药盘中异动 股价大涨5.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432694223","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432694223?lang=zh_cn&edition=full","pubTime":"2024-05-02 10:46","pubTimestamp":1714617967,"startTime":"0","endTime":"0","summary":"2024年05月02日早盘10时46分,翰森制药股票出现波动,股价急速拉升5.40%。截至发稿,该股报18.340港元/股,成交量184.469万股,换手率0.03%,振幅7.01%。翰森制药股票所在的药品行业中,整体涨幅为0.25%。翰森制药公司简介:翰森制药集团有限公司是一家主要从事药品研发、生产及销售业务的中国投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405021046077925aace&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405021046077925aace&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432469395","title":"南向资金4月30日净卖出翰森制药44.60万股 连续5日减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2432469395","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432469395?lang=zh_cn&edition=full","pubTime":"2024-05-02 09:30","pubTimestamp":1714613424,"startTime":"0","endTime":"0","summary":"4月30日,南向资金减持翰森制药44.60万股连续5日减持。截止当日收盘,港股通共持有翰森制药17318.83万股,占流通股2.90%。翰森制药近5个交易日上涨6.49%,港股通累计减持356.80万股;近20个交易日上涨12.40%,港股通累计减持943.80万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405020932298b6b7d95&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405020932298b6b7d95&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431867893","title":"翰森制药(03692):谭思慧已获委任为联席公司秘书","url":"https://stock-news.laohu8.com/highlight/detail?id=2431867893","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2431867893?lang=zh_cn&edition=full","pubTime":"2024-04-29 22:30","pubTimestamp":1714401051,"startTime":"0","endTime":"0","summary":"谭思慧已获委任为联席公司秘书,自2024年4月29日起生效。董事会宣布,新委任为联席公司秘书的谭思慧已获委任为授权代表及法律程序文件代理人,自2024年4月29日起生效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1115319.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2431886414","title":"翰森制药(03692)将于7月17日派发末期股息每股0.1422港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2431886414","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2431886414?lang=zh_cn&edition=full","pubTime":"2024-04-29 22:20","pubTimestamp":1714400403,"startTime":"0","endTime":"0","summary":"智通财经APP讯,翰森制药(03692)发布公告,该公司将于2024年7月17日派发末期股息每股0.1422港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1115288.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2431074520","title":"翰森制药04月29日主力资金流入453万元 连续5日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2431074520","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431074520?lang=zh_cn&edition=full","pubTime":"2024-04-29 16:16","pubTimestamp":1714378567,"startTime":"0","endTime":"0","summary":"04月29日, 翰森制药股价涨1.51%,报收17.48元,成交金额1.14亿元,换手率0.11%,振幅3.83%,量比1.30。翰森制药今日主力资金净流入453万元,连续5日净流入,上一交易日主力净流入594万元,今日环比减少23.74%。近一年数据显示,该股主力连续5日净流入后,次日上涨概率为80.00%,平均涨幅为4.34%。该股近5个交易日上涨8.60%,主力资金累计净流入2657万元;近20日主力资金累计净流入3639万元,其中净流入天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404291616528b60fcbc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404291616528b60fcbc&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431356020","title":"《半日速报》恒指升226点; 恒生科技指数升30点 友邦升逾7% 平安升逾3% 中行、翰森制药、海尔智家、小米集团、大新金融创新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2431356020","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2431356020?lang=zh_cn&edition=full","pubTime":"2024-04-29 12:12","pubTimestamp":1714363920,"startTime":"0","endTime":"0","summary":"恒指半日收17,878点,升226点或1.3%。恒生科技指数报3,748点,升30点或0.8%。国指升56点或0.9%,报6,326点。沽空资料截至 2024-04-26 16:25。","market":"other","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180301182030339_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180301182030339_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1345848/latest-news/AAFN","is_publish_highlight":false,"gpt_icon":0},{"id":"2431042969","title":"南向资金4月26日净卖出翰森制药35.00万股 连续3日减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2431042969","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431042969?lang=zh_cn&edition=full","pubTime":"2024-04-29 09:31","pubTimestamp":1714354292,"startTime":"0","endTime":"0","summary":"4月26日,南向资金减持翰森制药35.00万股连续3日减持。截止当日收盘,港股通共持有翰森制药17552.63万股,占流通股2.95%。翰森制药近5个交易日上涨11.96%,港股通累计减持332.80万股;近20个交易日上涨15.73%,港股通累计减持647.80万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404290947468b5fa923&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404290947468b5fa923&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430614220","title":"复宏汉霖曲妥珠单抗获FDA批准上市、翰森制药引进荃信生物一款自免单抗、一款国产PDE4抑制剂申报上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2430614220","media":"医药经济报","top":-1,"share":"https://www.laohu8.com/m/news/2430614220?lang=zh_cn&edition=full","pubTime":"2024-04-26 19:17","pubTimestamp":1714130264,"startTime":"0","endTime":"0","summary":"复宏汉霖曲妥珠单抗获FDA批准上市4月26日,美国FDA批准复宏汉霖曲妥珠单抗生物类似药上市,用于辅助治疗HER2过表达的早期乳腺癌、HER2过表达的转移性乳腺癌,以及HER2过表达的转移性胃腺癌或胃食管交界处腺癌。一款国产PDE4抑制剂申报上市近日,据CDE网站显示,和美药业的莫米司特申报上市。严重TEAEs的发生率与剂量有关,60mg组为3.3%,45mg组和安慰剂组均为0%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404261926128b570336&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404261926128b570336&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430406038","title":"翰森制药:荃信生物获独家许可 7500万元首付款最高10.32亿元里程碑付款","url":"https://stock-news.laohu8.com/highlight/detail?id=2430406038","media":"和讯网","top":-1,"share":"https://www.laohu8.com/m/news/2430406038?lang=zh_cn&edition=full","pubTime":"2024-04-25 18:31","pubTimestamp":1714041105,"startTime":"0","endTime":"0","summary":"4月25日,翰森制药全资附属公司翰森(上海)健康科技有限公司与荃信生物签署了一份许可协议,这一行为有望带来市场新的竞争格局。翰森(上海)健康科技有限公司将全权负责QX004N在中国的研发、生产及商业化,同时将支付7500万元的首付款以及最多10.32亿元的研发、监管及基于销售的商业化里程碑潜在付款,以及基于未来产品销售的分级特许权使用费。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404251930418b52da34&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404251930418b52da34&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430478975","title":"翰森制药(03692)附属与荃信生物订立许可协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2430478975","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2430478975?lang=zh_cn&edition=full","pubTime":"2024-04-25 16:40","pubTimestamp":1714034411,"startTime":"0","endTime":"0","summary":"智通财经APP讯,翰森制药 发布公告,于2024年4月24日,公司全资附属公司翰森(上海)健康科技有限公司与江苏荃信生物医药股份有限公司订立许可协议。根据许可协议,被许可人获得荃信生物的独家许可,以于中国开发及商业化QX004N单抗。截至本公告发布之日,QX004N已启动多项临床研究,在中国的最高研发阶段为II期临床试验。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1109794.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2430547898","title":"荃信生物-B(02509)与翰森(上海)健康科技就QX004N订立独家对外授权协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2430547898","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2430547898?lang=zh_cn&edition=full","pubTime":"2024-04-25 16:38","pubTimestamp":1714034294,"startTime":"0","endTime":"0","summary":"智通财经APP讯,荃信生物-B 发布公告,公司已于2024年4月24日与翰森(上海)健康科技有限公司就靶向IL-23p19的单克隆抗体抑制剂QX004N在中国内地、中国台湾、中国香港特别行政区及中国澳门特别行政区的研发、生产及商业化订立独家对外授权协议。公司保留QX004N在大中华地区以外的所有权利,可以继续对该药进行单药疗法或联合用药策略的开发。截至本公告日期,公司已启动QX004N的多项临床研究,在中国的最高研发阶段为II期临床试验。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1109785.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2430909478","title":"翰森制药(03692.HK)与荃信生物-B(02509.HK)签订QX004N对外授权协议 首付款7,500万人币","url":"https://stock-news.laohu8.com/highlight/detail?id=2430909478","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2430909478?lang=zh_cn&edition=full","pubTime":"2024-04-25 16:32","pubTimestamp":1714033920,"startTime":"0","endTime":"0","summary":"荃信生物-B公布,已于4月24日与翰森制药全资附属翰森(上海)健康科技就靶向IL-23p19的单克隆抗体抑制剂QX004N在中国内地、台湾、香港特别行政区及澳门特别行政区的研发、生产及商业化订立独家对外授权协议。翰森(上海)健康科技将负责QX004N所有可开发剂型和适应症于中国的研发、生产及商业化,并将支付7,500万元人民币(下同)首付款及不超过10.32亿元的研发、监管及基于销售的商业化里程碑潜在付款,以及基于未来产品销售的分级特许权使用费。","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180202161553962_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180202161553962_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1345106/latest-news/AAFN","is_publish_highlight":false,"gpt_icon":0},{"id":"2430420665","title":"翰森制药04月25日主力资金流入349万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2430420665","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430420665?lang=zh_cn&edition=full","pubTime":"2024-04-25 16:16","pubTimestamp":1714032998,"startTime":"0","endTime":"0","summary":"04月25日,翰森制药股价收平报16.80元,成交金额8298万元,换手率0.08%,振幅2.38%,量比0.88。翰森制药今日主力资金净流入349万元,连续3日净流入,上一交易日主力净流入187万元,今日环比增加86.63%。近一年数据显示,该股主力连续3日净流入后,次日上涨概率为58.82%,平均涨幅为2.16%。该股近5个交易日上涨7.28%,主力资金累计净流入1527万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流入2444万元,其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404251617368b521d1d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404251617368b521d1d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429300071","title":"翰森制药(03692)出现大手买入36.2万股,成交价$16.28,涉资589.336万","url":"https://stock-news.laohu8.com/highlight/detail?id=2429300071","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2429300071?lang=zh_cn&edition=full","pubTime":"2024-04-23 13:30","pubTimestamp":1713850200,"startTime":"0","endTime":"0","summary":"[大手成交]翰森制药(03692)在下午01:30出现大手买入,成交量为36.2万,成交价为港币$16.28,涉资589.336万。至目前为止,股价升1.496%,今日最高价为$16.3,而最低价为$15.94,总成交量为233.221万股,总成交金额港币$3.77千万。","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180205145550051_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180205145550051_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2404233037/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2429499276","title":"翰森制药盘中异动 下午盘股价大涨5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429499276","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429499276?lang=zh_cn&edition=full","pubTime":"2024-04-22 14:02","pubTimestamp":1713765777,"startTime":"0","endTime":"0","summary":"2024年04月22日下午盘14时02分,翰森制药股票出现波动,股价急速拉升5.06%。截至发稿,该股报16.160港元/股,成交量305.242万股,换手率0.05%,振幅5.07%。翰森制药股票所在的药品行业中,整体涨幅为0.34%。其相关个股中,开拓药业-B、泰凌医药、中国生物制药涨幅较大,振幅较大的相关个股有开拓药业-B、精优药业、泰凌医药,振幅分别为17.24%、10.71%、9.52%。翰森制药公司简介:翰森制药集团有限公司是一家主要从事药品研发、生产及销售业务的中国投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404221402577a54688a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404221402577a54688a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428763566","title":"翰森制药(03692)根据受限制股份单位的计划发行230万股公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2428763566","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2428763566?lang=zh_cn&edition=full","pubTime":"2024-04-19 17:20","pubTimestamp":1713518415,"startTime":"0","endTime":"0","summary":"智通财经APP讯,翰森制药(03692)发布公告,于2024年4月19日根据公司于2019年5月27日批准及采纳的受限制股份单位的计划发行230万股公司股份。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1105424.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2428571036","title":"南向资金4月18日净卖出翰森制药100.80万股 连续7日减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2428571036","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428571036?lang=zh_cn&edition=full","pubTime":"2024-04-19 09:31","pubTimestamp":1713490290,"startTime":"0","endTime":"0","summary":"4月18日,南向资金减持翰森制药100.80万股连续7日减持。截止当日收盘,港股通共持有翰森制药17852.43万股,占流通股3.00%。翰森制药近5个交易日下跌3.21%,港股通累计减持272.80万股;近20个交易日上涨3.30%,港股通累计增持863.52万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404190943348b384b21&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404190943348b384b21&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427869500","title":"翰森制药盘中异动 快速跳水5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2427869500","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427869500?lang=zh_cn&edition=full","pubTime":"2024-04-16 10:13","pubTimestamp":1713233583,"startTime":"0","endTime":"0","summary":"2024年04月16日早盘10时13分,翰森制药股票出现波动,股价快速跳水5.06%。截至发稿,该股报15.381港元/股,成交量148.032万股,换手率0.02%,振幅4.07%。机构评级方面,在所有19家参与评级的机构中,84%的券商给予买入建议,11%的券商给予持有建议,5%的券商给予卖出建议。翰森制药股票所在的药品行业中,整体跌幅为0.18%。翰森制药公司简介:翰森制药集团有限公司是一家主要从事药品研发、生产及销售业务的中国投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404161013037920c537&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404161013037920c537&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.0592},{"period":"1month","weight":0.1677},{"period":"3month","weight":0.6028},{"period":"6month","weight":0.2374},{"period":"1year","weight":0.2878},{"period":"ytd","weight":0.1574}],"compareEarnings":[{"period":"1week","weight":0.0467},{"period":"1month","weight":0.1047},{"period":"3month","weight":0.1894},{"period":"6month","weight":0.046},{"period":"1year","weight":-0.0738},{"period":"ytd","weight":0.0838}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"翰森制药集团有限公司是一家主要从事药品研发、生产及销售业务的中国投资控股公司。该公司的主要产品包括欧兰宁、阿美宁、普来乐、泽菲、昕维、昕美、泽坦、迈灵达、恒捷、恒森、孚来迪和瑞波特等。该公司产品主要用于中枢神经系统疾病、抗肿瘤、抗感染、糖尿病、消化道和心血管治疗。该公司主要在中国内地销售产品。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":-0.024511},{"month":2,"riseRate":0.4,"avgChangeRate":-0.000669},{"month":3,"riseRate":0.2,"avgChangeRate":-0.042173},{"month":4,"riseRate":0.6,"avgChangeRate":0.041694},{"month":5,"riseRate":0.8,"avgChangeRate":0.033747},{"month":6,"riseRate":0.5,"avgChangeRate":0.041662},{"month":7,"riseRate":0.4,"avgChangeRate":-0.048485},{"month":8,"riseRate":0.6,"avgChangeRate":-0.010974},{"month":9,"riseRate":0.4,"avgChangeRate":-0.05981},{"month":10,"riseRate":0.2,"avgChangeRate":0.031364},{"month":11,"riseRate":0.6,"avgChangeRate":0.050363},{"month":12,"riseRate":0.8,"avgChangeRate":0.06514}],"exchange":"SEHK","name":"翰森制药","nameEN":"HANSOH PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"翰森制药(03692)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供翰森制药(03692)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"翰森制药,03692,翰森制药股票,翰森制药股票老虎,翰森制药股票老虎国际,翰森制药行情,翰森制药股票行情,翰森制药股价,翰森制药股市,翰森制药股票价格,翰森制药股票交易,翰森制药股票购买,翰森制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"翰森制药(03692)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供翰森制药(03692)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}